(Q34768558)

4 August 2017

1 reference

title

Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. (English)

1 reference

sexually transmitted infection

4 August 2017

0 references

0 references

0 references

author name string

Jim A Turpin

series ordinal

1

1 reference

PubMed ID

12150703

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Expert Opinion on Investigational Drugs

4 August 2017

1 reference

4 August 2017

11

1 reference

4 August 2017

8

1 reference

4 August 2017

1077-1097

1 reference

HIV disease treatment in the era of HAART.

4 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Vaccine development against HIV-1: current perspectives and future directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Prophylactic contraceptives for HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Bacterial vaginosis and disturbances of vaginal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Incidence and impact of resistance against approved antiretroviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

HIV-1 drug resistance in newly infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Naturally occurring sequence polymorphisms within HIV type 1 group O protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Recommendations for the clinical development of topical microbicides: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

An Update on Vaginal Microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Progesterone implants enhance SIV vaginal transmission and early virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Functional and antigenic characterization of human, rhesus macaque, pigtailed macaque, and murine DC-SIGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Migration of Foreign Lymphocytes from the Mouse Vagina into the Cervicovaginal Mucosa and to the Iliac Lymph Nodes1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Detection of Human Immunodeficiency Virus DNA and RNA in Semen by the Polymerase Chain Reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

HTLV-III in Cells Cultured from Semen of Two Patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Phase 1 trial of nonoxynol-9 film among sex workers in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Microflora changes with the use of a vaginal microbicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: use of commercial lubricants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The plasma membrane as a combat zone in the HIV battlefield

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Structure and function of membrane rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Molecular Determinants of Nef Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Nef increases infectivity of HIV via lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Plasma membrane rafts play a critical role in HIV-1 assembly and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Pokeweed antiviral protein: ribosome inactivation and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-human immunodeficiency virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Novel thiourea compounds as dual-function microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Antiviral activity of tenofovir (PMPA) against nucleoside-resistant clinical HIV samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Anti-HIV effect of gramicidin in vitro: potential for spermicide use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Phase I/II dose escalation and randomized withdrawal study with add-on azodicarbonamide in patients failing on current antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Thymidine kinase-independent intracellular delivery of bioactive nucleotides by aryl phosphate derivatives of bromo-methoxy zidovudine (compounds WHI-05 and WHI-07) in normal human female genital tract epithelial cells and sperm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Suppressive effect of polyoxometalates on the cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) in vitro and their inhibitory activity against HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Mechanism of polyoxometalate-mediated inactivation of DNA polymerases: an analysis with HIV-1 reverse transcriptase indicates specificity for the DNA-binding cleft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Penetration of efavirenz into the male genital tract: drug concentrations and antiviral activity in semen and blood of HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Analysis of human immunodeficiency virus in semen: indications of a genetically distinct virus reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

C31G, a new agent for oral use with potent antimicrobial and antiadherence properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Acylcarnitine analogues as topical, microbicidal spermicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Sodium lauryl sulfate, a microbicide effective against enveloped and nonenveloped viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

CXCR4 function requires membrane cholesterol: implications for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Inhibition of human immunodeficiency virus replication by the sulfonated stilbene dye resobene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissocia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Mechanism of thrombospondin-1 anti-HIV-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Membranolytic selectivity of cystine-stabilized cyclic protegrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Protegrins: new antibiotics of mammalian origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Structural and functional similarities between synthetic HIV gp41 peptides and defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Ribosomal Inhibitory Proteins from Plants Inhibit HIV-1 Replication in Acutely Infected Peripheral Blood Mononuclear Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Development of vaginal microbicides for the prevention of heterosexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Structure-activity relationship studies on potential non-nucleoside DABO-like inhibitors of HIV-1 reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual-function spermicides with potent anti-human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Synthesis, characterization and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Evaluation of subchronic (13 weeks) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-05) in B(6)C(3)F(1) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Evaluation of subchronic (13-week) and reproductive toxicity potential of intravaginal gel-microemulsion formulation of a dual-function phenyl phosphate derivative of bromo-methoxy zidovudine (compound whi-07) in B(6)C(3)F(1) mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Development of an in vitro organ culture model to study transmissionof HIV-1 in the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Effect of PMPA and PMEA on the kinetics of viral load in simian immunodeficiency virus-infected macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.8.1077

10.1517/13543784.11.8.1077

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12150703